PICNet_CPO Public Report Q2_2018-19
[…] Highlights for Q 2 2018/19 (June 29 – September 20 , 2018 ) 66 carbapenemase resistance genes were newly identified from 6 3 isolates – 3 isolates harbor ed 2 differen t genes The NDM resistance gene accounted for the majority of genes identified (63.6 %) Surveillance information was reported for 44 new cases of CPO , including 4 new...
Type: Media